Antiretroviral therapy taken by people living with HIV decreases bone mineral density and increases fracture risk. Researchers investigated whether osteoporosis drugs denosumab and zolendronate could help men living with both osteoporosis and HIV.
Researchers conducted a study to determine whether government cash programs and programs that incentivize school attendance decrease the incidence of HIV infection among young women and adolescent girls.
Researchers evaluated the virologic and immunologic characteristics of a patient with previously confirmed HIV infection who had an undetectable HIV viral load for more than 7 years after discontinuing antiretroviral therapy.
Investigators conducted a study to assess the rates of high-risk sexual behavior and sexually transmitted infections among men who have sex with men before and after the introduction of HIV pre-exposure prophylaxis.
Researchers conducted a study to determine whether patients with untreated HIV infection have consistently decreased cerebrospinal fluid HIV RNA viral loads vs plasma HIV RNA throughout various stages of the disease.